Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484145 · ClinicalTrials.gov registry record · Phase 2
Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
A Phase 2 study of Onychomycosis, sponsored by Nitric BioTherapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01484145 is a Phase 2 study of Onychomycosis that has completed, run by Nitric BioTherapeutics. The registered enrollment target is 25 participants, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01484145, a Phase 2 study of Onychomycosis, has completed, sponsored by Nitric BioTherapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how much terbinafine is delivered to the nail bed after treatment with a number of modifications to a previously studied method for iontophoretic delivery of terbinafine gel. Iontophoretic delivery involves the use of a small electric charge to deliver drug across skin and nails.
Conditions Studied
Interventions
- DRUG Terbinafine HCl
Study Locations (1)
Texas
- Cetero Research - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484145
The ClinicalTrials.gov registry entry for NCT01484145 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (73% lower). The listed sponsor is Nitric BioTherapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Terbinafine HCl is the first listed.
NCT01484145 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01484145 about?
NCT01484145 is a clinical study titled "Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail". The purpose of this study is to determine how much terbinafine is delivered to the nail bed after treatment with a number of modifications to a previously studied method for iontophoretic delivery of terbinafine gel. Iontophoretic delivery involves the use of a small electric charge to deliver drug ...
What is the current status of trial NCT01484145?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2011-12. Estimated completion is 2012-04.
What conditions does trial NCT01484145 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT01484145?
The interventions under investigation include: Terbinafine HCl (DRUG).
Who is sponsoring clinical trial NCT01484145?
This trial is sponsored by Nitric BioTherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01484145 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
-
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
COMPLETED · Phase 2
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Spread of Dermatophytes Among Families
COMPLETED
-
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.